Self-Destructing Syringe Market Size, Share, and Industry Analysis, By Type (3ml, 5ml, 10ml, 20 ml, and Others), By Application (Drugs, Vaccines, Aesthetics, and Others), By End-user (Hospitals, Specialty Clinics, and Others), and Regional Forecast, 2025-2032

Self-destructing syringes are designed to prevent the reuse of needles and syringes, which can spread deadly diseases such as hepatitis and human immunodeficiency virus (HIV). These syringes have a mechanism that makes them unusable after a single injection. This is typically achieved through a locking mechanism that prevents the plunger from being pulled back or using a syringe material that breaks or deforms after use.

In developing countries, the goal is to eliminate the ability to reuse syringes, where unsafe injection practices are common. This helps protect patients from contracting infections and reduces the risk of needlestick injuries to healthcare workers, driving the adoption of such needles, which is expected to boost the market growth in the forthcoming years. The self-destructing syringe market growth is primarily attributed to the increasing prevalence of chronic diseases worldwide, which requires frequent injections and drives the need for safe, disposable syringes. This is expected to surge the adoption of self-destructing syringes during the forecast period.

Furthermore, the high burden of blood-borne diseases such as hepatitis is also expected to boost the market growth in the forthcoming years. Reuse of needles and syringes has been a significant public health concern, as it increases the risk of transmitting infectious diseases, including HIV and hepatitis. Self-destructing syringes help address this issue by making it impossible to reuse the needle after a single injection, preventing the spread of such diseases.

• For instance, as per the article published by Liaoning KANGYI Medical Equipment Co., Ltd in January 2024, a 2014 study sponsored by the World Health Organization (WHO), out of the 1.7 million individuals who contracted hepatitis B, approximately 33,800 had HIV. Around 315,000 people got hepatitis C as a result of reusing syringes and needles.

Moreover, the ongoing educational campaigns and initiatives to raise awareness about the benefits of self-destructive syringes are helping healthcare providers and the general public understand the importance of using these safer alternatives to traditional syringes. This is anticipated to surge the market growth in the coming years.

The COVID-19 pandemic significantly impacted the global self-destructing syringe market in 2020. The pandemic increased the overall demand for vaccines and injections, which had driven the adoption of self-destructive syringes to ensure the safe administration of therapeutics, and the prevention of disease transmission during the pandemic. 

Segmentation

Key Insights

The report covers the following key insights:

• Prevalence of Key Diseases, By Key Countries/Region, 2023
• Overview: Technological Advancements in Self-Destructing Syringe
• Key Industry Developments (Mergers, Acquisitions, Partnerships)
• Impact of COVID-19 on the Market   

Analysis by Type

Based on the type, the market is classified into 3ml, 5ml, 10ml, 20 ml, and others. The 5ml segment is projected to account for a significant share of the global self-destructing syringe market during the forecast period. The 5ml self-destructing syringes are a common size used for many standard medication doses and injections. These syringes are most often used for intramuscular injections or only the injections that are given directly into the muscles. In consideration of this high usage, there is an increasing awareness and adoption of these products with advanced safety measures in several healthcare settings. Healthcare settings are progressively integrating the 5 ml self-destructing syringes to enhance patient safety and comply with the stringent healthcare regulations, which is expected to boost segmental growth in the coming years.

On the other hand, the 3ml segment is anticipated to grow at a significant CAGR during the forecast period. The growth of this segment is attributed to the high volume of syringe usage in hospital settings, driven by the need for safe and reliable medical procedures. 3ml syringes are most often used for diabetics, the administration of the drug in hospitals, vitamin deficiencies, and other intramuscular injections. Furthermore, the implementation of self-destructing syringes in hospitals is crucial to prevent needlestick injuries and reduce the risk of infection transmission among healthcare workers and patients. This is expected to boost the product adoption, driving the segment growth in the coming years.

• For instance, as of June 2024, Retractable Technologies, Inc. stated that the top 10 U.S. hospitals use their VanishPoint syringes, which are also available in 3ml capacity.

Regional Analysis

To gain extensive insights into the market, Download for Customization

The global market is geographically segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is expected to hold a significant share of the self-destructing syringe market during the forecast period. The region's market growth is attributed to the increasing recommendation of self-destructing syringes for various immunization programs to decrease the spread of diseases in the region. Moreover, the benefits associated with these products, such as ease of use, reliability, and affordability of these vaccines, are expected to boost their adoption in the region, propelling the market growth in the coming years.

Asia Pacific is projected to grow significantly during the forecast timeframe. Governments and healthcare authorities have formulated policies and regulations that mandate the use of self-destructive syringes, which are expected to fuel the regional market growth. Moreover, the key players focusing on expanding the production volume of self-destructing syringes are expected to increase the product's availability and affordability, driving the region's market growth.

• For instance, in November 2020, Hindustan Syringes & Medical Devices Ltd announced the production plan of 177.6 million 0.5 ml KOJAK auto-disable syringes for the Indian government by March 2021.

Key Players Covered

The market consists of significant players, such as Changzhou Shuangma Medical Devices Co., Ltd., SPM Medicare, Yangzhou Goldenwell Medical Devices Factory, BD, Abbott, Ningbo Greetmed Medical Instruments Co., Ltd., and Weigao Group.

Key Industry Developments

• In March 2024, Hindustan Syringes & Medical Devices Ltd launched Dispojekt, an indigenous single-use safety syringe, to reduce the risk of needle stick injuries.
• In September 2023, Revital announced that it received a pre-qualification (PQ) status from the World Health Organization (WHO) in July 2023 for its early activation auto-disable (AD) syringe in Africa.
• In November 2020, Hindustan Syringes & Medical Devices Ltd shipped more than 100 million pieces of KOJAK auto-disable syringes to the Covax stockpile facility as the COVID-19 vaccines showed promising results globally.